Targeted Therapy for Breast Cancer: 251 Real Stories

251 stories match breast cancer and targeted therapy. 200 of them mention chemotherapy.

A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

HER2-Positive Recurrent Breast Cancer Treated With Multiple Targeted and Local Therapies

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: 2008 recurrence: ER 80%, HER2 FISH amplified. 2011 recurrence: ER 80%

Metastatic Site: liver, skin

After 25 cycles of eribulin, treatment was still ongoing; nodal disease remained stable, while later imaging also noted new metabolic activity in the upper lung.

PubMed Central
OutcomeCare Ongoing
Lindsey, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Lindsey's Patient Story

Patient Info: Lindsey Ballas, Female | Stage IV

Metastatic Site: Not reported

As of September 2017, Lindsey was living with Stage IV metastatic breast cancer on advanced targeted maintenance therapy every 3 weeks, with stable disease and continued work and family life.

Cleveland Clinic
OutcomeLiving With Cancer
Sarah, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HER2-Positive Breast Cancer: Sarah's Patient Story

Patient Info: Sarah, Female, Under 40 | Stage IV

Biomarkers: HER2-positive; BRCA and other known hereditary breast cancer genes not identified in family history discussion

As of January 2017, Sarah had been living for almost 3 years with recurrent Stage IV HER2-positive breast cancer and was receiving Kadcyla every 3 weeks.

YouTube — Oncology Associates
OutcomeLiving With Cancer
Debora, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Debora's Patient Story

Patient Info: Debora, Female, 60s | Stage IV

Debora was living with metastatic breast cancer after Stage III disease treated with surgery, chemotherapy, radiation therapy, and targeted therapy; four years after surgery, she was told the cancer had metastasized and was on targeted therapy.

Our Cancer Stories
OutcomeLiving With Cancer
HR
Breast Cancer

HER2-Positive Right Breast Cancer With Complete Response Before Bilateral Mastectomy

Patient Info: Anonymized, female, 50s

Biomarkers: ER negative, PR negative, HER2 positive

After neoadjuvant treatment, imaging showed complete resolution of the right-breast mass and mastectomy pathology found no residual right-breast tumor or malignant right sentinel node.

PubMed Central
OutcomeResponding Well
Liu, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Liu's Patient Story

Patient Info: Liu Jing | Stage IV

More than eight years after a stage 4 diagnosis, Liu Jing remained on hormone and targeted therapies and continued working, walking, and mountain hiking.

Our Cancer Stories
OutcomeLiving With Cancer
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Recurrent HER2-amplified breast cancer: complete remission on trastuzumab-based therapy

Patient Info: Anonymized, Female, 40s | Stage Metastatic/Advanced

Biomarkers: Primary tumor was ER/PR negative and HER2 not amplified. Recurrent lymph-node disease became ER/PR positive and HER2 amplified by FISH.

Metastatic Site: left axillary and infraclavicular lymph nodes

After HER2-amplified nodal recurrence, paclitaxel plus trastuzumab produced complete clinical remission; she continued trastuzumab monotherapy with tolerable neuropathy.

PubMed Central
OutcomeResponding Well
Su, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Su's Patient Story

Patient Info: Su Chiao | Stage IV

Metastatic Site: bones, thymus, liver

After 7 years, the breast cancer had spread to the bones and thymus, and more recently it spread to the liver, where she underwent embolization.

Our Cancer Stories
OutcomeSetback / Progression